Add-on value of tirzepatide versus semaglutide
André Scheen
Topics & Concepts
MedicineType 2 diabetesInsulin resistanceIncretinSemaglutideDiabetes mellitusGlucagon-like peptide 1 receptorDulaglutideInternal medicineEndocrinologyInsulinAdverse effectPharmacologyAgonistLiraglutideReceptorBioinformaticsBiologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer